BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 9, 2026
Breaking News: Regeneration in mammals is controlled by environmental conditions
See today's BioWorld Science
Home
» Science in 2025: the best of the rest
To read the full article
sign up for free
or
sign in
.
The year in review
Science in 2025: the best of the rest
Dec. 31, 2025
By
Mar de Miguel
and
Anette Breindl
No Comments
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
BioWorld Science
Drug design, drug delivery and technologies
Aging
Cancer
Endocrine/metabolic
Immune
Neurology/psychiatric
